Clinical Proteomics
News on proteomics applications for clinical use in genetics, genomics, and molecular diagnostics.
MARAbio Systems Closes $19M Funding Round to Support Autism Test Commercialization
The company has developed a blood-based test to assess whether women are carriers of the antibodies that cause maternal autoantibody related-autism.
The company is targeting its RPPA-based testing to biopharma firms as well as for clinical trial work and to clinicians to help guide therapy in cancer patients.
C2N Diagnostics Receives $15M From GHR Foundation for Development of Tau Tests for Alzheimer's
The tests will measure blood-based tau markers, offering a possible alternative to PET imaging for aiding in diagnosis and staging of Alzheimer's disease.
UltraDx Bio Receives Chinese Clinical Registration Approval for UD-X Immunoassay Analyzer
With the approval, the UD-X analyzer, which uses Quanterix's single-molecule array technology, can be used for clinical applications in China.
New Blood Test Shows 90 Percent Accuracy in Diagnosing Alzheimer’s Disease
Developed by researchers from Lund University in Sweden, the test is more accurate than doctors’ diagnoses using standard clinical evaluation tools.